Merck Acquires Terns Pharmaceuticals for $6.7B
Merck buys Terns Pharmaceuticals for $6.7B, gaining leukemia drug TERN-701 to offset Keytruda's 2028 patent cliff. Learn what this means for CML t...
#MerckTerns #TERN701 #CML #MRK #BiotechMergers
https://scrollworthy.org/trending/terns-pharmaceuticals
0
0
0
0